KAHR Announces Publication of Preclinical Data Indicating Monotherapy and Combination Treatment Potential of its Investigational Anti-CD47 Fusion Protein

Press/Media: Expert Comment › Popular

Period	15-Mar-2022

Media coverage

Title	PR Newswire Global Biotech
Media name/outlet	PR Newswire Global Biotech
Media type	Other
Date	15/03/2022
URL	https://bionj.org/news/pr-newswire-global?rkey=20220315LN91306&filter=16221
Persons	Edwin Bremer